Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB05256_nanopub.RASAB8qda3WxoBT0ODa8RI7DNoqBmkH64bYERPblTI1Ag#assertion>. }
Showing items 1 to 12 of
12
with 100 items per page.
- drugbank:DB05256 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05256 label "659032 [drugbank:DB05256]" assertion.
- drugbank:DB05256 seeAlso DB05256 assertion.
- drugbank:DB05256 description "659032 is the third genomics-derived small-molecule drug coming from a collaboration between Human Genome Sciences and GlaxoSmithKline to enter clinical development. 659032 is a second lipoprotein-associated phospholipase A2(Lp-PLA2) inhibitor." assertion.
- drugbank:DB05256 identifier "drugbank:DB05256" assertion.
- drugbank:DB05256 title "659032" assertion.
- drugbank:DB05256 drugbank_vocabulary:x-cas cas: assertion.
- drugbank:DB05256 drugbank_vocabulary:drugbank-id "DB05256" assertion.
- drugbank:DB05256 bio2rdf_vocabulary:x-identifiers.org DB05256 assertion.
- drugbank:DB05256 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05256" assertion.
- drugbank:DB05256 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05256 bio2rdf_vocabulary:identifier "DB05256" assertion.